AHSA Drug Regulation Changes

The AHSA recently announced the adoption of two amendments to the Drugs and Medications Rule that was proposed by the Drugs and Medications Committee at a meeting in July. Each change would serve to liberalize an aspect of the Drugs and Medications Rule and to accommodate the interests of trainers and exhibitors.

The first amendment deals with the concentration of meclofenamic acid (Arquel) in the blood, and the second changes requirements of reporting non-steroidal anti-inflammatory drugs (NSAIDs). Both the amendments and an explanation by John Lengel, DVM, Administrator of the Drugs and Medications Program can be viewed at www.ahsa.org.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners